Cyclobenzaprine hydrochloride
- Product NDC
- 52817-191
- 11-digit product format
- 528170191
- Labeler code
- 52817
- Product ID
- 52817-191_14722df1-fa89-43f3-acd5-864f14df7fdc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cyclobenzaprine hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- TruPharma, LLC
- Application
- ANDA073541
- Marketing category
- ANDA
- Marketing start
- 2017-08-09
- Marketing end
- 0000-00-00
- Substance
- CYCLOBENZAPRINE HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 52817-191-00 | 52817019100 | 1000 TABLET in 1 BOTTLE (52817-191-00) | 1000 tablet | 2017-08-09 | 0000-00-00 | No | No | Current |
| 52817-191-10 | 52817019110 | 100 TABLET in 1 BOTTLE (52817-191-10) | 100 tablet | 2017-08-09 | 0000-00-00 | No | No | Current |
| 52817-191-50 | 52817019150 | 500 TABLET in 1 BOTTLE (52817-191-50) | 500 tablet | 2017-08-09 | 0000-00-00 | No | No | Current |